ICAM1 and neoplasm: The results of mean fluorescence intensity of in vivo imaging showed that ICAM1-specific CAR-T cells were effective in reducing the tumor sizes in MDA-MB-231 xenograft tumors (p < 0.01) (Figures 5B,D,E).